Acceleron Pharma IncMost RecentCompany & Industry OverviewsAcceleron Pharmaceuticals and Celgene Rise on Meeting Study GoalsToday, Celgene (CELG) and Acceleron Therapeutics (XLRN) stocks are trending higher on the news of their Phase 3 clinical trial for luspatercept meeting its goal.
Company & Industry OverviewsAcceleron Pharmaceuticals and Celgene Rise on Meeting Study GoalsToday, Celgene (CELG) and Acceleron Therapeutics (XLRN) stocks are trending higher on the news of their Phase 3 clinical trial for luspatercept meeting its goal.
